This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here
News and Events
SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB5
Santiago de Compostela (Spain) / Wuhan (China), September, 2025 — SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies,…
Galician company SunRock launches itself onto the world stage from Biopolo with an innovative anti-tumor drug
Link: https://www.elcorreogallego.es/economia/2025/10/06/gallega-sunrock-proyecta-mundo-biopolo-122301872.amp.html
DEBIOPHARM LICENSES SUNROCK BIOPHARMA’S ANTI-HER3/HER2 ANTIBODY TO EXPLORE THE FULL POTENTIAL OF BISPECIFIC ADC DEBIO 2512
Lausanne, Switzerland and Santiago De Compostela, Spain – September 30th, 2025 – Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company today announced…
Events
SunRock Biopharma, S.L will be attending the BIO-Europe 2025 in Vienna from 3-5 November
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
UEG Week 2025: SunRock along with Dr. Manuel Barreiro presented promising results with its anti-CCR9 antibodies in IBD
SunRock participated in UEG Week 2025, held in Berlin from October 4 to 7, where our collaborator Dr. Manuel Barreiro, Head…
SunRock Biopharma will be presenting results on its anti-CCR9 antibody for IBD in a poster at UEG Week, Berlin 2025
Our Manager, Juan Buela and Elia Alvarez, our Senior Scientist, will be attending UEG Week 2025 in Berlin (October 4–7), and…
SunRock Biopharma, S.L will be attending the BIOInternational 2025 in Boston from 16-19 June
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma, S.L will be attending the BIOEquity 2025 in Bruges from 12-14 May
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma, S.L will be attending the BIOEurope Spring 2025 in Milan from 17-19 March
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma will be attending the 20th Congress of ECCO European Crohn’ and Colitis Organisation in Berlin from 19-22 February
We are a hashtag#biotech company with a pipeline of therapeutic hashtag#antibodies for the treatment of hashtag#inflammatory hashtag#bowel hashtag#disease. Are you attending…
Projects
